Certain information identified by [***] has been omitted from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. LICENSE AGREEMENT BETWEEN RELMADA THERAPEUTICS, INC. AND ARBORMENTIS, LLCLicense Agreement • August 10th, 2021 • Relmada Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 10th, 2021 Company Industry JurisdictionThis agreement (“Agreement”) is entered into as of July 16, 2021 (the “Effective Date”), by and between Arbormentis, LLC, a Delaware limited liability company (“Licensor”) and Relmada Therapeutics, Inc., a Nevada corporation (“Licensee”).